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Summary 
The fetal mouse omentum has been shown to be a source of precursors that exclusively reconstitutes 
Lyl + B cells and the closely related Lyl-  sister population,  but not conventional B cells or T 
cells. We have extended these studies to compare B cell development in the human fetal omentum, 
liver,  and spleen, and to demonstrate that  the pro/pre-B cell compartment  (CD24 +,  sIgM-) 
is detected in the omentum and liver but not spleen as early as 8 wk of gestation.  From 8 to 
12 wk of gestation,  the proportions of IgM + cells that were pre-B cells (cIgM + AIgM-) in the 
omentum  and liver were 53  _+  15%  and 45  _+  13%,  respectively, and IgM §  cells  were not 
detectable in the spleen. After 12 wk, the percentage of pre-B cells was unchanged in the fetal 
liver (41  _+  10%) but decreased significantly in the omentum  (25  •  14%);  pre-B cells were 
now detected in the spleen but at much lower percentages (2  •  3%) than either the omentum 
or liver.  The nuclear enzyme, Tdt, was detected in approximately 25% of the CD24 + cells in 
the omentum and liver during the 8-12-wk time period, however, Tdt + cells were not detected 
in the spleen. Approximately 40% of the mature B cells found in the omentum and spleen were 
CD5 § compared with only 20% in the liver. These results demonstrate that the fetal omentum, 
like the fetal liver and bone marrow,  is a primary  site of B cell development. 
T 
he mouse fetal liver is an early site of hematopoiesis and 
a rich source of stem cells capable of reconstituting  all 
hematopoietic  lineages  including  Lyl +  B  cells  (1,  2).  At 
16-17 d of gestation, hematopoiesis begins to shift from the 
liver to the bone marrow where it is maintained throughout 
adult life (3).  However, adult bone marrow,  in contrast to 
fetal liver, only poorly reconstitutes Lyl + B cells, which has 
led to the suggestion that Lyl B cells were derived from dis- 
tinct  precursors  that  are present  in the fetus but absent in 
the adult (2). More recently, it has been shown that mouse 
B cell precursors from fetal liver give rise in vitro and in vivo 
to CD5 + B cells, whereas bone marrow precursors with the 
same phenotype give rise only to conventional B cells  (4). 
In this connection we have recently demonstrated that  the 
fetal mouse omentum contains precursors that give rise ex- 
clusively to Lyl + B cells and the closely related Lyl-  sister 
population but not conventional B cells or T cells (5). These 
findings raise the possibility that very early during develop- 
ment Lyl + B cells are generated in a compartment  distinct 
from  that  for conventional B  cells. 
Lyl + B cells differ from conventional B cells in their sur- 
face phenotype, tissue localization,  and immunoglobulin reper- 
toire (6-15).  The most intriguing  characteristic of Lyl + B 
cells in mice and CD5 + (human Lyl homologue) B cells in 
humans is the production of antibodies with affinity for self- 
antigens. Many antibody specificities,  including rheumatoid 
factor activity, anti-DNA,  and anti-T cell reactivity, appear 
to be enriched in this B cell subset (9-12). The best studied 
reactivity of these B cells in mice is the in vitro affinity for 
bromelain-treated  mouse red blood cells (13).  The overrep- 
resentation of this specificity within Lyl + B cells is clearly 
the result of antigen selection, however, the mechanism for 
the segregation of this antibody specificity or the nature of 
its physiological counterpart in vivo is unclear (14,  15). Al- 
though  there is an association between increased levels of 
CD5 + B cells in certain autoimmune diseases such as rheu- 
matoid arthritis in humans and in the autoimmune NZB mice 
(6,  16), CD5 + B cells have not been shown to secrete patho- 
genic autoantibodies, and the exact role they play in the eti- 
ology of autoimmune  disease is not  known. 
The human fetal liver is also an early site of hematopoiesis 
(17).  Pre-B  cells  (clgM+AIgM -)  are  first  detectable  in 
human fetal life at 0,8 wk of gestation,  and it is not until 
o,12 wk that peripheralization  of B cells occurs (18). A re- 
port from Bofill et al. (19) using immunohistochemical tech- 
niques described the appearance of CD5 B cells in the human 
fetal peritoneal and pleural cavity at 15 wk of gestation, how- 
ever, these cells were absent from the liver before 16 wk and 
were rare in the bone marrow. This led the authors to com- 
ment that the "original derivation of these cells is a mystery" 
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of precursors for Lyl  + B cells, we have compared B cell de- 
velopment in the human fetal omentum, liver, and spleen. 
In this report,  we demonstrate that B cell development 
occurs simultaneously in situ in the human fetal liver  and 
omentum but not spleen, and that B cells from the omentum 
showed a bias  towards CD5 expression. 
Materials  and Methods 
Fetal Samples.  Fetal  liver, spleen, and omentum were obtained 
from elective  abortion samples received  from The Central Labora- 
tory for Human Embryology, University of Washington (Seattle, 
WA), and gestational age was estimated by foot length. 
Preparation of  Single Cell Suspensions.  The fetal liver, omentum, 
and spleen were dissected and placed in 1 ml of a 50% solution 
of Dispase II (Boehringer Mannheim Biochemicals, Indianapolis, 
IN) in complete RPMI with 5% FCS. The samples were placed 
in Eppendorf tubes and put on an orbital shaker (Fisher Scientific 
Co., Pittsburgh,  PA), at speed 400 for 1 h at 37~  The single 
cell suspensions were then centrifuged and washed two times in 
complete KPMI (Gibco  Laboratories,  Grand Island, NY) with 10% 
FCS and stained for flow cytometry as described below. 
Antibodies.  mAbs  against CD5 and CDllb were purchased from 
Becton Dickinson & Co. (Mountain View, CA). The anti-CD24 
(IgM,  g) mAb, BA-1 (20), was provided by Dr. Tucker Lebien 
(University  of  Minnesota), and the anti-CD24 (IgG1, K) mAb, SN3, 
was provided by Dr. Ben Seon (Roswell Park Cancer Center). The 
anti-CD45RO antibody, HB11, has been described  previously  (21). 
The goat anti-mouse IgGI-PE, anti-mouse IgG-biotin, anti-human 
IgM-FITC, and anti-human IgM-ILITC  antibodies  were purchased 
from Southern Biotechnology Associates  (Birmingham, AL). The 
FITC and RITC anti-human IgM antibodies were extensively  ab- 
sorbed on mouse Ig coupled to Sepharose 4B before use. The anti- 
Tdt antibody was purchased from Supertechs (Bethesda, MD). 
Immunofluorescence Staining.  The protocol for staining  pre-B ceils 
and mature B cells has been described  elsewhere (22). We also added 
1 #1 of I  rag/m1 Hoescht dye to 250 ml of the final PBS wash 
to facilitate  counting of nucleated  cells. To quantitate the percentage 
of cells with phenotypes described in Fig. 4, three aliquots of cells 
were stained  with anti-CD24 (IgM, K) followed  by anti-mouse IgM- 
FITC. Cytocentrifuge preparations were made and fixed in meth- 
anol for 20 rain. One slide  was then stained with anti-human IgM- 
P,  ITC to allow calculation  of the percentage of the IgM  +/CD24 + 
cells. The  second slide was  stained with anti-Tdt followed by 
anti-mouse IgG biotin and finally Streptavidin-Texas  red (SATR)  t 
for calculation of the percentage of Tdt +/CD24 + cells. To calcu- 
late the percentage of Tdt-/IgM-/CD24 + cells, the last slide was 
stained with anti-Tdt, then anti-mouse  IgG biotin  followed by 
SATR, and finally the anti-human IgM-RITC. 
For flow cytometric analysis, cells were stained with the anti- 
bodies indicated  in the text using the following regimen. Cells were 
stained in a 96-well round-bottomed plate. 10 #1 of the appropriate 
antibody was added for 10 rain on ice and the cells were washed 
once with 200 #1 of PBS/FCS followed by the next antibody as 
indicated. The samples were fixed in 1% paraformaldehyde  (pH 
7.4) and analyzed on a FACScan  |  (Becton Dickinson & Co.). 
Immunohistochemicat Analysis of Tissu~  To detect IgM § cells in 
the fetal omentum, this tissue was embedded in paraffin, sectioned 
1Abbreviations used in  this paper: c,  cytoplasmic; s,  surface; SATR, 
Streptavidin-Texas red. 
and processed for immunofluorescence staining as previously de- 
scribed (23). The sections were stained with goat anti-human IgM- 
FITC. Serial sections were also stained with hematoxylin and eosin 
(H&E). 
Results 
Histology of the Human Fetal Omentum.  A photomicro- 
graph of 10-wk-old human fetal omentum and spleen is shown 
in Fig.  1 A. During fetal life, the omentum is a thin trans- 
parent well vascularized membrane with clusters of erythro- 
cytes associated with the vasculature (Fig. 1 B). Immunoflu- 
orescent staining using FITC-conjugated anti-human IgM 
showed that B lineage cells could be detected along the pe- 
riphery of these erythroid areas (Fig.  1 C). B cells were also 
found in loose loci or as isolated cells throughout the mesen- 
tery without any association with the vasculature. 
The Pro/Pre-B Compartment  Is Present in Both  the Fetal 
Omentum and Liver.  CD24 is expressed  on B lineage cells 
as early as the pro-B cell stage (24, 25) and was used in com- 
bination with anti-IgM to identify pro/pre-B cells (CD24 + , 
surface  IgM-  [slgM-])  and  mature  B  cells  (CD24 +, 
slgM+).  This  permitted  us  to  determine  the  ratio  of 
pro/pre-B  cells  to  mature  slgM +  B  cells  (pro/pre-B:B) 
during fetal development. Fig. 2 shows representative staining 
profiles of cell suspensions of omentum, liver, and spleen from 
16 wk of gestation. Pro/pre-B cells are displayed in the upper 
left (UL) quadrant and mature B cells in the upper right (UR) 
quadrant. The ratio of pro/pre-B:B cells from 13-23  wk of 
gestation was 1.2:1 in both omentum (n  =  8) and liver (n 
=  8); in contrast, the ratio of pro/pre-B:B cells in the fetal 
spleen (n  --  5) during this time was 0.07:1. During the ear- 
lier  10-12-wk  gestation period,  this ratio  was  4:1  in  the 
omentum (n  =  3) and liver (n  =  3),  while B lineage cells 
were not detected at this time in the spleen (n  =  3).  The 
pro/pre-B cell compartment was detected even earlier,  at 8 
wk of gestation in the omentum and liver, however, because 
of the low frequency of bright CD24 + cells at this stage, 
we could not calculate  the pro/pre-B:B cell ratio. 
Pre-B Cell Development Is Similar in the Fetal Omentum and 
Liver at 8-12 wk of Gestation.  The percentage of cytoplasmic 
IgM + (clgM +) cells that were pre-B  cells (clgM+/slgM -) 
in the 8-12-wk period was determined by immunofluores- 
cence microscopy (Fig. 3).  In the fetal omentum and liver, 
the percentage ofpre-B cells was 53 +  15 and 45 _+  13, respec- 
tively, while B lineage cells were undetectable in the spleen 
during this time period. After the 8-12-wk period, the per- 
centage of pre-B  cells was unchanged in the fetal liver  (41 
+_  10) but was significantly lower in the omentum (25  _+  14). 
These results may indicate that the development of B cells 
in the fetal omentum is transitory, however, we cannot rule 
out the possibility that the pre-B cells are simply being diluted 
by mature B cells seeding to the periphery during this time 
period. Analysis of fetal omentum from the last trimester 
is needed to address this question, however, fetal tissue from 
these late gestational ages are not available. Beginning at '~12 
wk, pre-B cells were detected in the spleen (2  +_  3) but at 
much lower percentages  than either the liver or omentum. 
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old human  fetal  omentum, stomach, and spleen. 
The fetal omentum is a thin mesenteric mem- 
brane  (large arrow) which  hangs  from  the 
stomach into the peritoneal cavity. The spleen 
(small arrow) develops as a thickening of the 
mesenchyme of the omentum and is purely 
mesoderm in origin (x 10). (B) Hematoxylin 
and eosin (H & E)-stained section of a folded 
12-wk human fetal omentum, which demon- 
strates the membraneous  nature of the fetal 
omentum and the presence of erythrocytes and 
lymphoid ceils  in the perivascular  space (x 100). 
(C) Immunofluorescence staining of sections 
of  human fetal omentum. Sections  were stained 
with FITC anti-lgM, and B ceils can be seen 
in the perivascular spaces (x400). r 
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Figure  2.  Pro/pre-B  cell com- 
partment  is  detected  in  16-wk 
human  fetal omentum,  liver, and 
spleen. Cells were stained with anti- 
CD24 followed by anti-mouse IgG1 
PE  and  finally  anti-human  IgM 
FITC. The pro/pre-B cell compart- 
ment is detected in the upper  left 
quadrant (CD24 +  AIgM-) and the 
mature slgM + B cells are seen in 
the upper right quadrant.  Relevant 
percentages  are indicated. 
The percentages  of IgM § cells (both clgM + and slgM +)  50 q 
per total nucleated cells in the omentum and liver were 0.74  ~ 
_+  0.6 and 0.42  +  0.5 during the 8-12-wk period and 2.1  40 
_+  2.6 and 1.5  +_  1.3 during the 13-24-wk period, respec- 
tively. Thus, the omentum contains approximately twice as 
many IgM + cells per nucleated cells as the liver during both  30 
the early and late developmental periods. 
Tdt + B Lineage  Cells Were Detected at 8 wle of Gestation in  20 
Both  the Fetal Omentum and Liver.  Tdt has been associated 
with immunoglobulin  gene rearrangement  (26) and N  re- 
gion addition in vitro (27), and is believed to be expressed  10 
in B lineage cells at the pro-B cell stage immediately before  r  t~ 
the expression of cIgM (28).  CD24 § B lineage cells from  ~  0 
fetal omentum and liver were analyzed for the presence or  r  1 O0 
absence of Tdt and IgM. The results of this analysis are shown  .o 
in Fig. 4. The phenotype of each group is indicated diagra- 
matically in the order of the progression that is believed to  n  8o 
occur during normal B cell development (28). It can be seen 
that the distribution  of B lineage phenotypes  within each 
group was remarkably  similar between omentum and liver 
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Figure 3.  Percentage of pre-B cells total IgM + cells in omentum, liver, 
and spleen at 8-12-wk vs. 13-23 wk. Cells were stained first with FITC 
anti-human IgM, to detect surface IgM expression. Cytocentrifuge prepa- 
rations were made and stained with RITC anti-human IgM to detect cy- 
toplasmic lgM. Pre-B cells were identified as cIgM  +/sIgM-, the data are 
presented  as the percentage  of pre-B cells/total IgM + cells, and SE bars 
are indicated.  No IgM + cells were detected in the fetal spleen before 12 
wk of gestational  age. 
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Figur, 4.  Percentage of CD24 § B lineage cells e~pressing Tdt or IgM 
in omentum, liver, and spleen from 8-10 (a) and 18-20 (b) wk of gesta- 
tion. Cell were stained first with anti-CD24, then anti-mouse IgM FITC. 
Cytopreparations  were then stained with one of the following: anti-Tdt 
then biotin conjugated anti-IgG, followed by SATR, and finally anti-human 
IgM RITC to determine the percent of Tdt- Ig-/CD24 +; anti-Tdt, fol- 
lowed by biotin conjugated  anti-IgG,  and finally SATR to determine  the 
percentage of Tdt +/CD24§  or anti-human IgM RITC to determine the 
proportion  of IgM+/CD24 § . One cytopreparation was stained with and- 
Tdt,  then  biotin conjugated  anti-IgG,  followed  by SATR,  and  finally 
anti-human IgM FITC to detect Tdt*/IgM + cells. No CD24" cells were 
detected in the spleen during this time point. The phenotypes  detected 
are indicated  on the x-axis. 
400  Human Fetal Omentum and B Cell Generation tr) 
0 
OMENTUM 
~-.. ,4  .: 
"'~.  . .  ~  .  _'~ ~1.~  1.1 
LIVER 
0.3 
i  1.5 
anti-lgM 
SPLEEN 
l 
J 
3.7 
5.0 
Figure 5.  Presence  of  CD5 B  cells 
in omentum,  liver, and spleen  at 14 
wk. Cells  were stained  with CDS- 
PE followed  by anti-human IgM 
FITC. Markers were set using an 
isotype-matched  control  (IgG2a-PE) 
for CD5  with anti-human IgM 
FITC (data not shown). Relevant 
percentages are indicated. 
during both the early and late developmental time periods. 
One striking difference between the two age groups was the 
marked decrease in the large population of Tdt-/IgM- cells 
during the late time period; this decrease occurred concomi- 
tant with an increase in the percentage of clgM + cells (both 
pre-B  and mature B) during this time. CD24 + cells were 
not detected in the spleen between 8 and 10 wk, however, 
CD24 + cells were easily detected in the spleen at 18-20 wk. 
The phenotype of these cells was typically that of peripheral 
B cells, since '~98% of the B lineage cells in the spleen were 
slgM +,  and Tdt was not detected. 
Percentage of CD5 + B Cells Is Higher in the Omentum than 
Livez.  Mature B  cells  (slgM +)  are  detected in  sufficient 
numbers to confidently calculate  the percentage of CD5 +, 
IgM+/total IgM + cells in the omentum and liver  at '~14 
wk of gestation. Cells from 14-17 wk gestation fetal tissues 
were stained with CD5-PE plus anti-IgM as indicated in Fig. 
5.  Markers were set for each tissue type based on staining 
with an irrelevant isotype-matched control and anti-IgM. The 
percentage of CD5 + B cells/total B cells was equal in the 
omentum and spleen at 43  _+  11 (n  =  6) and 41  _+  13 (n 
=  4),  respectively.  However,  the percentage of CD5 + B 
cells in the liver was substantially lower at 21  _+  3 (n  =  5). 
Pro/pre-B cells  Mature B cells 
(CD24+IslgM  ")  (CD24+/slgM  +) 
A 
CD5 
B 
Figure 6.  Analysis  of pro/pre-B cells and mature B cells for expression 
of CDS. Three-color flow cytometric  analysis was used to analyze  the 
pro/pre-B cells and mature  B cells separately.  Cells were stained  first  with 
biotin-conjugated CD24, followed  by SA-tandem; next, the cells were 
stained with anti-human  IgM-FITC,  and finally  CD5-PE. Analysis  gates 
were set to collect only the bright CD24  § cells. The pro/i~re-B cells 
(CD24 +  AIgM) are shown  in A; the mature B cells (CD24  §  are 
shown in B. 
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A variety of antibodies against other B cell surface markers 
were used in an attempt to determine if (1)  the CD5-  B 
cells in the omentum were the CD5-  "sister" population 
and (2) omental B cells could be further distinguished from 
those in the fetal liver. Mac-1 is expressed on mouse CD5 + 
B cells as well as the CDS-  sister  population but not on 
conventional B cells. However, <0.1% of the slgM + B cells 
in either the omentum or liver expressed CDllb, the human 
analogue of Mac-1. In addition, there were no differences in 
the ratios of intensity of IgM and IgD expression by B cells 
in the omentum vs. liver. CD45RO, detected by mAb HBll, 
was expressed  on the B cells from the omentum at a 20% 
higher level than B cells from the fetal liver (n  =  3) (data 
not shown). Thus, using the available markers, we have been 
unable to determine if, in addition to the higher frequency 
of CD5 B cells present in the omentum, they are homogene- 
ously distinct from those in the fetal liver. 
As can be seen in both omentum and spleen,  relatively 
large numbers of CD5 + T  cells were detected (UL quad- 
rant) which were absent or rare in the fetal liver. The T cells 
found in the omentum and spleen expressed  either c~/~ or 
~,/6 TCRs in a ratio that indicated that they were most likely 
mature T cells which at this time have migrated to the pe- 
riphery. 
Analysis of Pro/Pre-B Cells for the Presence of the CD5 An- 
tigen.  Three-color flow cytometry was used to determine 
when the CD5 antigen first  appeared  during development 
of B cells. Analysis gates were set to analyze exclusively B 
lineage cells using CD24 as a pan-B cell marker in conjunc- 
tion with anti-IgM FITC and CD5-PE; the pro/pre-B cells 
(slgM-)  (Fig.  6 A) and the mature B cells (slgM +) (Fig. 
6 B) were analyzed separately for the expression  of the CD5 
antigen. The cells in the pro/pre-B cell compartment failed 
to express CDS, while it was easily detected on slgM + B 
cells. 
Discussion 
The human perinatal and adult omentum is considered part 
of the lymphoid system because it contains loose unorganized 
lymphoid aggregates called "milk spots" (29). Despite its ac- 
tivity as a secondary lymphoid organ, there has been no analysis 
of the fetal omentum with respect to the generation of lym- phocytes in situ in development or in the adult. In this study 
we show that  the pro/pre-B  cell compartment  (CD24 + / 
slgM-),  pre-B cells  (clgM +/slgM-),  and  Tdt +  B lineage 
ceils can be detected as early as 8 wk of gestation in the human 
fetal omentum. These results demonstrate that B cell gener- 
ation occurs in situ in the human fetal omentum concomi- 
tant  with  that  occurring  in  the fetal liver. 
Pro/pre-B cells were detected as early as 8 wk of gestation 
in the fetal omentum at a time when the pro/pre-B:mature 
B cell ratio is similar in the omentum and liver.  In contrast, 
this compartment of the B cell lineage was not detected in 
the spleen until ~12 wk of gestation.  In addition,  the per- 
centage of pre-B/IgM + cells in the fetal omentum and liver 
was approximately the same during the early 8-12-wk time 
period. However, during the 13-23-wk period, the percent- 
age of pre-B cells/IgM + cells decreased significantly in the 
omentum, while remaining at the same level in the liver. These 
results are consistent with the idea that the development of 
B cells  in  the omentum  is transitory,  however,  analysis  of 
fetal omentum from later gestational ages is needed to deter- 
mine the length of time that  the fetal omentum maintains 
the ability to generate B lineage ceils in situ.  Additionally, 
during the 13-23-wk time period, pre-B cells became detect- 
able in the spleen but at a much lower frequency than that 
seen in either  the liver or omentum. 
Tdt + cells have been detected in the fetal liver as early as 
7 wk of gestation (30) and are believed to represent a stage of 
B cell development during which gene rearrangements occur 
(25-27). Here we report that ~25%  of the CD24 + cells in 
both the fetal omentum and liver from 8-12 wk of gestation 
express the nuclear antigen Tdt.  Interestingly,  almost 30% 
of the CD24 + cells present in both tissues during the time 
period are negative for Tdt and IgM.  This population was 
not described in a report from Nishimoto et al. (28) in anal- 
ysis of CD19 + B lineage cells from fetal bone marrow. This 
may reflect the presence of the CD24 antigen on B lineage 
cells at a more immature stage than CD19. Alternatively, this 
population may represent the earliest B lineage cells, and are 
present in large enough numbers to be detected only during 
very early gestation in fetal liver and omentum but not in 
later fetal bone marrow. 
These results clearly demonstrate that every identifiable stage 
in B cell differentiation is detected in both the fetal omentum 
and liver as early as 8 wk of gestational age. This is in con- 
trast to the fetal spleen, a peripheral secondary lymphoid organ, 
where little B cell generation  appears  to occur in humans 
and very few ceils of immature phenotype are detected at any 
stage of development.  The  presence of B  cell progenitors 
in liver and omentum at a time when they are undetectable in 
spleen also argues against  the origin of these cell types in 
either  organ  as blood-borne contaminants. 
Examination of mature B cells demonstrated a higher per- 
centage of CD5 + B cells in the omentum and spleen com- 
pared  with  the  fetal  liver.  However,  in  the  human  fetal 
omentum  and  spleen,  >50%  of the  B  ceils  were CD5-, 
similar to our results obtained by reconstitution of scid mice 
with fetal mouse omentum (5). In mice, the closely related 
Lyl-  sister population  is well characterized,  and we were 
able to  identify the Lyl-  B  cells  as the  sister population. 
Since, at the moment, there are no useful phenotypic markers 
to  distinguish  the  CD5-  sister  population  from  conven- 
tional B cells in humans, we cannot determine whether the 
CD5-  B cells present in the human  omentum  are equiva- 
lent  to  the CD5-  sister population. 
Although we have proposed that the mouse fetal omentum 
may provide a unique milieu that directs immature cells along 
the CD5 B cell lineage,  there is evidence that  CD5 B cell 
generation may be a general property of fetal B lineage differen- 
tiation (4). Our results, although suggestive that the omentum 
may constitute an enriched source of CD5 cells,  obviously 
needs further comparative data with respect to differentia- 
tion antigen and V  region usage by the B cell populations 
from liver and omentum. There is an alternative hypothesis 
related to CD5 B cell development proposed by Conget al. 
(31),  which  suggests  that  crosslinking  of slgM on  newly 
emerging B cells stimulates the expression of the Lyl antigen. 
Although our results do not directly support this hypoth- 
esis, we have clearly shown that the CD5 antigen does not 
appear until or after the expression of slgM. This is in con- 
trast to CD5 expression by human and mouse T cells, which 
occurs early in thymocytes before TCR expression (32, 33). 
The contemporaneous expression of CD5 with slgM during 
development of B cells suggests that the expression of both 
surface proteins  may be linked. 
Our earlier work in mice (5)  and this report in humans 
show that the fetal omentum is a site where B cells are gener- 
ated,  thus raising the question as to the significance of the 
fetal omentum in B cell development in other species. B cell 
development as judged by the presence of pre-B cells also occurs 
in the fetal omentum in rabbits (our unpublished data).  At 
this point we do not know if the B cells  generated in the 
fetal rabbit  omentum  express the CD5  antigen.  However, 
this observation, in addition to the work presented here and 
our previous work with fetal mouse omentum, demonstrates 
that  this site is conserved through evolution in a variety of 
mammals as a site of B cell generation and should be consid- 
ered along with  the fetal liver,  thymus,  and bone marrow 
as a primary lymphoid organ during the development of the 
immune  system. 
We thank Hiromi Kubagawa, Nori Nishimoto,  and Pete Burrows for their advice, and Ann Brookshire 
for preparation  of this manuscript. 
This work was supported by National  Institutes  of Health grants  CA-13148, AI-30879, AI-14782, and 
402  Human  Fetal Omentum and B Cell Generation HD-00836, awarded  to the Central Laboratory  for Human Embryology, University  of  Washington, Seattle. 
N. Solvason is supported by NIH training grant 5 T32 AR-07450-09. 
Address correspondence  to Nanette Solvason, 263 Tumor Institute, University of  Alabama at Birmingham, 
Birmingham, AL 35294. 
Received for publication 13 August  1991. 
References 
1. Jordan, C.T., J.P. McKearn, and I.R. Lemischka. 1990. Cel- 
lular and developmental  properties of fetal hematopoietic stem 
cells. Cell. 61:953. 
2.  Hayakawa,  K., R.R. Hardy, L.A. Herzenberg, and L.A. Her- 
zenberg. 1985. Progenitors for Lyl B cells are distinct from 
progenitors for other B cells.  J. Exp. Med. 161:1554. 
3.  Velardi,  A., and M.D. Cooper. 1984. Immunofluorescence  anal- 
ysis of the ontogeny of  myeloid, T and B lineage cells in mouse 
hemopoietic tissues.  J. Immunol. 133:672. 
4.  Hayakawa, K., and R.R. Hardy. 1991. Generation of Lyl B 
cells from developmentally  distinct precursors: enrichment by 
stromal cell culture or cell sorting. Ann. NYA_cad. Sci. In press. 
5.  Solvason,  N., A. Lehuen, andJ.F. Kearney.  1991. An embryonic 
source of  Lyl but not conventional  B cells. Int. Immunol. 3:543. 
6.  Hayakawa, K., R.R. Hardy, D.R. Parks, and L.A. Herzen- 
berg.  1983. The Lyl B cell subpopulations in normal, im- 
munodeficient and autoimmune mice. J. Exp. Med. 157:202. 
7.  Kehry,  M.R., and S.A. Hudak.  1989. Characterization of B 
cell populations  bearing  FeE  receptors II.  Cell. lmmunol. 
118:504. 
8.  Waldschmidt, T.J., F.G.M.  Kroese,  L.T. Tygrett, D.H. Conrad, 
and R.G. Lynch. 1991. The expression  of  B cell surface  receptors. 
III. The murine low affinity IgE FcrR is not expressed on Lyl 
or "Lyl-like" B cells. Int. Immunol. 3:305. 
9.  Casali, P., S.E. Burastero, M. Nakamura, G. Inghirami, and 
A.L. Notkins.  1987. Human lymphocytes making rheuma- 
toid factor and antibody to ssDNA belong to Leu-1  + B cell 
subset. Science (Wash. DC). 236:77. 
10.  Hardy, R.R., K. Hayakawa, M. Shimizu, K. Tamasaki, and 
T. Kishimoto. 1987. Rheumatoid factor secretion from human 
Leu-1 B cells. Science (Wash. DC). 236:81. 
11.  Hayakawa,  K., R.R. Hardy, M. Hands, L.A. Herzenberg, A.D. 
Steinberg, and L.A. Herzenberg. 1984. Lyl B cells: function- 
ally distinct lymphocytes  that secrete IgM autoantibodies.  Proc. 
Natl. Acad. Sci. USA.  81:2492. 
12.  Hayakawa, K., C.E. Carmack, R. Hyman, and R.R. Hardy. 
1991. Natural autoantibodies  to thymocytes: origin, V, genes, 
fine specificities, and the role of Thy-1 glycoprotein. J. Exp. 
Med. 172:869. 
13.  Mercolini, T.J., L.W. Arnold, and G. Haughton. 1986. Phos- 
phatidyl choline is recognized by a series of Lyl murine B cell 
lymphomas specific for erythrocyte membranes,  j. Exp. Med. 
163:155. 
14.  Pennell, C.A., K.M. Sheehan, P.H. Brodeur, and S.H. Clarke. 
1989. Organization and expression of VH gene families pref- 
erentially expressed by Lyl (CD5) B cells. Eur. J. Immunol. 
19:2115. 
15.  Carmack, C.E., S.A. Shinton, K. Hayakawa,  and R.R. Hardy. 
1990. Rearrangements and selection of V,11 in the Ly-1 B cell 
lineage. J. Exp. Med. 172:371. 
16.  Plater-Zyberk, C., R.N. Maini, K. Ram, T.D. Kennedy, and 
G. Janossy. 1985. A rheumatoid arthritis B cell subset expresses 
403  Solvason  and Kearney 
a phenotype similar to that in chronic lymphocytic leukemia. 
Arth. Rheum. 28:971. 
17.  Bloom, W.,  and G.W. Bartelmez. 1940. Hematopoiesis in 
young human embryos. Am. J. Anat.  67:21. 
18.  Lawton, A.R., K.S. Self,  S.A. Royal, and M.D. Cooper. 1972. 
Ontogeny ofB lymphocytes  in the human fetus. Clin. Immunol. 
Immunopath. 1:84. 
19.  Bofill, M., G. Janossy, M. Janossy, G.B. Burford, G.J. Sey- 
mour, P. Wernet, and E. Keleman. 1985. Human B cell devel- 
opment II. Subpopulation in the human fetus.  J. Immunol. 
134:1531. 
20.  Abramson, C.S., J.H. Kersey,  and T.W. LeBien. 1981. A mono- 
clonal antibody (BA-1) reactive with cells of human B lym- 
phocyte lineage. J. Irnmunol. 126:83. 
21.  Tedder, T.F., M.D. Cooper, and L.T. Clement. 1985. Human 
lymphocyte differentiation antigens HB-10 and HB-11. II. 
Differential production of B cell growth and differentiation 
factors by distinct helper T cell subpopulations.  J. Immunol. 
134:192. 
22.  Raft,  M.C.,J.J. Megson, and M.D, Cooper. 1976. Early  produc- 
tion of intracellular IgM by lymphocyte precursors in mouse. 
Nature (Lond.). 259:224. 
23.  Sainte-Marie, G.  1962. A paraffin embedding technique for 
studies employing  irnmunofluorescence.J.  Histochem. Cytochem. 
10:250. 
24.  Hofman, F.M., M. Brock, C.R. Taylor, and B. Lyons. 1988. 
IL-4 regulated differentiation and proliferation of human pre- 
cursor B cells.  J. Immunol. 141:1185. 
25.  Hofman, F., J. Danilous, L. Husmann, and C.R. Taylor. 1984. 
Ontogeny of B cell markers in the human fetal liver. J. Im- 
munol. 133:1197. 
26.  Kunkel,  T.A., K.P. Gopinathan, D.K. Dube, E.T. Suon, and 
L.A. Loeb. 1986. Rearrangements of DNA mediated by ter- 
minal transferase. Proa Natl. Acad. Sci. USA.  83:1867. 
27.  Desiderio, S.V., G.D. Yancopoulos, M. Paskind, E. Thomas, 
M.A. Boss, N. Landau, F.W. Alt, and D. Baltimore. 1984. In- 
sertion of N regions into heavy-chain  genes is correlated with 
expression of terminal deoxy nucleotidyltransferase  in B cells. 
Nature (Lond.). 311:752. 
28.  Nishimoto, N., H. Kubagawa, T. Ohno, G.L. Gartland, A. 
Stankovic, and M.D. Cooper. 1991. Normal pre-B cells express 
a receptor complex of Mu heavy chains and surrogate light 
chain proteins, Proc. Natl. Acad. Sci. USA.  88:6284. 
29.  Borisov, A.V. 1964. Lymphatics capillaries and blood vessels 
of milky spots in the human greater omentum, Fed.  Proa 23:150. 
30.  Abe, J. 1989. Immunocytochemical characterization of lym- 
phocyte development  in human embryonic  and fetal  livers. Clin. 
Immunol. Immunopath. 51:13. 
31.  Cong,  T.,  E.  Rabin,  and  H.  Wortis.  1991. Treatment of 
CD5- B cells with anti-Ig but not LPS, induces surface CD5: 
two B cell activation pathways. Int. ImmunoI. 3:467. 
32.  Fowlkes, B.J., L. Edison, B.J. Matthieson, and T.M. Chused. 1985. Early T lymphocytes. Differentiation in vivo of adult in- 
trathymic precursor cells. J. Extx Med. 162:802. 
33.  Knowles, D.M. 1989. Immunophenotypic and antigen receptor 
gene rearrangement analysis in T cell neoplasia. Am.J. Pathol. 
134:761. 
404  Human Fetal Omentum and B Cell Generation 